Skip to content

A study to assess and compare the therapeutic efficacy of Trayoshanadi Anjana and its modulated ointment form in external eye infections in specific in bacterial conjunctivitis

A Comparative study on Antimicrobial And Clinical Effect of Trayoshanadi Anjana and its Modulated Ointment Form In EOIM ( External Ocular Infection Management ) wsr(with special reference) to Bacterial Conjunctivitis - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062269
Enrollment
252
Registered
2024-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H102- Other acute conjunctivitis

Interventions

None listed

Sponsors

Parul Institute of Ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with signs and symptoms of any of the external ocular infections Patients providing consent for the trial Patients comfortable to undergo the treatment procedures of the trial

Exclusion criteria

Exclusion criteria: Patients presenting with external ocular inflammatory signs which are not due to a bacterial infection

Design outcomes

Primary

MeasureTime frame
Trayoshanadi Anjana and its modulated ointment form are clinically efficacious in Bacterial conjunctivitis when used once for a period of 7 daysTimepoint: Assessed on 7th day of patients study

Secondary

MeasureTime frame
Trayoshanadi Anjana modulated ointment form is more clinically efficacious compared to Trayoshandi anjanaTimepoint: Will be assessed on 7th day of patient study

Countries

India

Contacts

Public ContactDr Eshwari Salian

Parul Institute of Ayurveda

manishanaringe@gmail.com9726073938

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026